April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 billion Respironics litigation settlement reached in the US ...
Read MoreThe Society for Immunotherapy of Cancer (SITC), the world's leading member-driven organization dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy, is pleased to announce the publication ...
Read MoreFirst procedures were successfully performed under local anesthesia in an office setting by Steven Gange MD FACS, Summit Urology, Utah . YOKNEAM, Israel , Aug. 3, 2022 /PRNewswire-PRWeb/ -- Butterfly Medical , an Israeli medical ...
Read MoreMore than half of pregnant and breastfeeding women nationwide believe there is not enough awareness surrounding the existence of lactation support services. ASHEVILLE, N.C. , Aug. 3, 2022 /PRNewswire-PRWeb/ -- Aeroflow Breastpumps , a ...
Read MoreRESEARCH TRIANGLE PARK, N.C. , Aug. 3, 2022 /PRNewswire/ -- A new study by experts at RTI International, a nonprofit research institute, estimates that a one-year increase in alcohol consumption during the COVID-19 pandemic will have a ...
Read More- Commentary points to need for a vaccine based on nucleocapsid vs. spike protein to make vaccine less vulnerable to mutation and provide stronger immunity to novel viral variants - Company's development of a nucleocapsid vaccine, a ...
Read MoreEnable Biosciences Reports Easier and Accurate SARS-CoV-2 Neutralizing Antibody Assay using Dried Blood Spot Samples SOUTH SAN FRANCISCO, Calif. , Aug. 3, 2022 /PRNewswire/ -- Scientists at Enable Biosciences report a novel method to ...
Read MoreCAMBRIDGE, Mass. , Aug. 3, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for ...
Read MoreHANGZHOU, China , Aug. 3, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that its innovative drug LNK01004, has been approved by ...
Read More- STP0404 is the only clinical safety proven HIV treatment candidate with a novel mechanism that can block HIV re-activation. - STP0404 is expected to enter Phase 2a clinical trial in the US in 4Q 2022. SEOUL, South Korea , Aug. 3, 2022 ...
Read MoreSUZHOU, China , Aug. 3, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced that the ...
Read MoreBened Life, Inc. releases its first product, Neuralli™ SAN FRANCISCO , Aug. 3, 2022 /PRNewswire-PRWeb/ -- Bened Life is releasing the first gut-brain medical probiotic, Neuralli™, on Wednesday, August 3, 2022 . Made in the United States ...
Read MoreKEY POINTS TADIOS was determined to be safe and well tolerated Serum levels of IL-1RA changed significantly, a biomarker that has a correlation with severity and mortality during COVID-19 infections Improvement in fatigue observed LA ...
Read MoreVIKEN, Sweden , Aug. 3, 2022 /PRNewswire/ -- A new study with TikoMed's lead drug candidate, ILB®, addressing underlying causes of neurodegeneration in acute and chronic diseases, was published in the International Journal of Molecular ...
Read More-- ASC10 is an oral double prodrug that is rapidly and completely converted in vivo into the active metabolite ASC10-A, which is the same active metabolite of molnupiravir -- Ascletis has filed multiple patent applications for ASC10 and its ...
Read MoreHAMBURG, Germany , Aug. 3, 2022 /PRNewswire/ -- Vela Diagnostics has announced its appointment by the National Public Health Laboratory of Kenya (NPHL) as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund. ...
Read More- Robust HbA1c reduction of 2.4% was observed with 1.2 mg XW003 dose - Up to 88% of participants achieved HbA1c = 7% and up to 72% achieved HbA1c = 6.5% at the end of the 20-week treatment - XW003 was safe and well tolerated with ...
Read MoreMultiyear campaign will highlight clinical evidence and patient impact of MRIdian for cancer treatment CLEVELAND , Aug. 2, 2022 /PRNewswire/ -- ViewRay, Inc, the U.S. maker of the MRIdian System, today announced a partnership with ...
Read MoreThe specialists at the Endometriosis Treatment Center of America believe that excision of endometriosis is the best way for treatment and use pathology reports to help guide women in finding expert care. DETROIT , Aug. 2, 2022 ...
Read MoreAugust is Breastfeeding Awareness Month, and World Breastfeeding Week (WBW) will be celebrated Aug. 1-7 this year. DETROIT , Aug. 2, 2022 /PRNewswire-PRWeb/ -- Breastfeeding has many known health benefits for mother and baby and is ...
Read MoreSubscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers